China SXT Pharmaceuticals, Inc.

SXTC · NASDAQ
Analyze with AI
3/31/2025
3/31/2024
3/31/2023
3/31/2022
Assets
Cash & Equivalents$18,099$12,070$17,368$15,524
Short-Term Investments$0$0$0$0
Receivables$1,900$1,346$1,345$5,525
Inventory$828$810$531$1,018
Other Curr. Assets$469$7$277$385
Total Curr. Assets$21,296$14,233$19,521$22,452
Property Plant & Equip (Net)$355$565$1,268$1,591
Goodwill$0$0$0$0
Intangibles$12$19$28$39
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$8,310$8,737$9,465
Total NC Assets$367$8,894$10,033$11,094
Other Assets$0$0$0$0
Total Assets$21,664$23,127$29,554$33,546
Liabilities
Payables$1,158$1,280$1,378$1,482
Short-Term Debt$772$2,353$3,391$2,046
Tax Payable$1,031$1,052$1,105$1,168
Deferred Revenue$59$188$166$77
Other Curr. Liab.$2,992$4,030$8,458$12,348
Total Curr. Liab.$6,012$8,902$14,497$17,122
LT Debt$212$295$366$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$212$295$366$0
Other Liabilities$0$0$0-$3,606
Cap. Leases$177$236$306$0
Total Liabilities$6,224$9,197$14,863$17,122
Equity
Pref Stock$0$0$0$0
Common Stock$44,531$4,352$914$162
Retained Earnings-$28,015-$24,712-$21,613-$15,688
AOCI-$1,076-$1,026-$198$956
Other Equity$0$35,316$35,588$30,994
Total Equity$15,440$13,930$14,691$16,425
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$21,664$23,127$29,554$33,546
Net Debt-$17,115-$9,423-$13,612-$13,478
China SXT Pharmaceuticals, Inc. (SXTC) Financial Statements & Key Stats | AlphaPilot